New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
09:14 EDTMPEL, WYNN, LVS, MGM, ELN, BIIB, VMED, ZNGA, TWX, GDP, RS, RL, DIS, LBTYA, MUSA, SFLYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Disney (DIS), up 2.8%... Time Warner (TWX), up 2.7%... Shutterfly (SFLY), up 16.9%... Zynga (ZNGA), up 5.5%... Ralph Lauren (RL), up 4.9%... ALSO HIGHER: Goodrich Petroleum (GDP), up 12.1% after announcing well results... Biogen (BIIB), up 5% after deal to pay $3.25B to acquire full rights and control of Tysabri from Elan (ELN)... DOWN AFTER EARNINGS: C.H. Robinson (CHRW), down 7.1%... Suncor (SU), down 3.7%... Hain Celestial (HAIN), down 2.7%... ALSO LOWER: Las Vegas Sands (LVS), down 2%, Melco Crown (MPEL), down 3.2%, MGM Resorts (MGM), down 1.3%, and Wynn Resorts (WYNN), down 3.4%, after The Times of London said China's government will begin clamping down on Macau junket operators... ACQUISITIONS MOVERS: Metals USA (MUSA), up 12.8%, to be acquired by Reliance Steel (RS) for $20.65 per share... Virgin Media (VMED), down 1.5%, to be acquired by Liberty Global (LBTYA) in cash and stock deal valued at $23.3B.
News For DIS;TWX;SFLY;RL;ZNGA;MUSA;RS;VMED;LBTYA;GDP;BIIB;ELN;LVS;MPEL;MGM;WYNN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 22, 2015
19:02 EDTWYNN, LVS, MGMOn The Fly: After Hours Movers
Subscribe for More Information
16:03 EDTLVSLas Vegas Sands reports Q2 adjusted EPS 60c, consensus 61c
Subscribe for More Information
15:26 EDTLVSNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Qualcomm (QCOM), consensus 95... American Express (AXP), consensus $1.32... Texas Instruments (TXN), consensus 65c... Las Vegas Sands (LVS), consensus 61c... Crown Castle (CCI), consensus $1.06... Discover Financial (DFS), consensus $1.32... Tractor Supply (TSCO), consensus $1.11... SanDisk (SNDK), consensus 33c... SL Green Realty (SLG), consensus $1.56... Xilinx (XLNX), consensus 54c... Weatherford (WFT), consensus (12c)... F5 Networks (FFIV), consensus $1.60... United Rentals (URI), consensus $1.74... Fortinet (FTNT), consensus 9c... LaSalle Hotel (LHO), consensus 89c... Oceaneering International (OII), consensus 68c... Cheesecake Factory (CAKE), consensus 62c.
13:02 EDTLVSLas Vegas Sands technical notes ahead of earnings
Subscribe for More Information
12:27 EDTTWX, DISTime Warner's HBO lands sports commentator Bill Simmons
Subscribe for More Information
12:21 EDTTWX, DISTime Warner's HBO announces multiyear deal with Bill Simmons
Bill Simmons left Disney's (DIS) ESPN earlier this year.
10:59 EDTBIIBBiogen drops after reporting data on Alzheimer's drug
The shares of Biogen (BIIB) are falling after the company released data on its Alzheimer's treatment candidate, aducanumab. Peer Eli Lilly (LLY) also reported data this morning on its own experimental Alzheimer's drug, solanezumab. BIOGEN: Biogen's data "does not inspire confidence," Piper analyst Joshua Schimmer wrote in a note to investors today. The 6 mg dose of the drug performed similarly to the 1mg dose, and was barely better than the placebo, the analyst stated. The cognitive and functional performance of the patients who took the 6 mg dose did not improve by a statistically significant amount, while the results of patients taking the other doses were "noisy,"Schimmer stated. Additionally, indications of excess fluid in the brain was observed in a significant number of patients, representing an additional problem for the treatment, the analyst believes. The data "is far from inspiring confidence" and makes the outlook for aducanumab "more speculative than ever," Schimmer contended. LILLY: Also this morning, Eli Lilly presented results from a pre-specified secondary analysis of several Phase 3 studies at the Alzheimer's Association International Conference. According to the company, the results suggest the treatment effect of solanezumab was preserved within a pre-specified amount in patients with mild Alzheimer's disease who received solanezumab earlier in the disease compared to patients who began treatment at a later point. Treatment differences in cognition and function between early-start and delayed-start groups at the end of the placebo-controlled period were preserved at the primary time point of 108 weeks within a pre-defined margin. Treatment differences in cognition and function between early-start and delayed-start groups at the end of the placebo-controlled period were also preserved at an additional time point of 132 weeks within a pre-defined margin.The differences at 108 weeks and at at 132 weeks remained statistically significant, the company said. PRICE ACTION: In morning trading, Biogen fell 3% to $397.43 while Eli Lilly shares rose 0.6% to $86.11.
10:01 EDTBIIBOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:28 EDTBIIBBiogen downgraded to Neutral at Piper Jaffray after Alzheimer's data
Subscribe for More Information
09:22 EDTBIIBBiogen downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
09:07 EDTBIIBOn The Fly: Pre-market Movers
Subscribe for More Information
07:19 EDTBIIBBiogen drops 4.8% to $390 after reporting Alzheimer's drug data
06:50 EDTBIIBBiogen's Alzheimer's candidate shows reduction of clinical decline
Subscribe for More Information
06:41 EDTLVSLas Vegas Sands volatility elevated into Q2 and outlook
Subscribe for More Information
July 21, 2015
12:43 EDTDISEarnings Watch: Analysts expect GoPro to beat expectations in Q2
Subscribe for More Information
06:24 EDTBIIBPiper expects 'stronger, bolder' move from Biogen
Subscribe for More Information
06:12 EDTBIIBBiogen implied volatility of 50 at upper end of index
July 20, 2015
07:32 EDTBIIBAlzheimer's Association to hold a conference
Subscribe for More Information
July 19, 2015
15:43 EDTDISDisney's 'Ant-Man' leads U.S. weekend box office with $58M
For the weekend of July 19, Disney's (DIS) "Ant-Man" topped domestic box office charts at $58M. Comcast (CMCSA, CMCSK) subsidiary Universal's "Minions" landed in second place with $50.2M, while Universal's "Trainwreck" came in third with $30.2M. Disney's "Inside Out" and Universal's "Jurassic World" took fourth and fifth place at $11.7M and $11.4M, respectively. Data gathered by Rentrak.
13:47 EDTWYNNWynn Resorts could be 'long-term winner' if Macau improves, Barron's says
Shares of Wynn Resorts look "potentially cheap" ahead of a possible recovery in Macau gambling, Barron's contends in a 'Trader Extra' column. The publication calls Wynn "one of the best-managed companies in the sector," and though Macau could worsen, "stabilization by next year" is the more likely outcome, says Barron's. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use